Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 202.48 USD -1.39% Market Closed
Market Cap: 487.8B USD

Relative Value

The Relative Value of one JNJ stock under the Base Case scenario is hidden USD. Compared to the current market price of 202.48 USD, Johnson & Johnson is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

JNJ Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
19
vs Industry
28
Median 3Y
4.4
Median 5Y
4.6
Industry
2.6
Forward
5.1
vs History
63
vs Industry
16
Median 3Y
18.8
Median 5Y
21.8
Industry
21.8
Forward
18.4
vs History
7
vs Industry
27
Median 3Y
17
Median 5Y
16.4
Industry
16.7
vs History
38
vs Industry
26
Median 3Y
15.6
Median 5Y
16.1
Industry
22.7
vs History
1
vs Industry
13
Median 3Y
5.3
Median 5Y
5.5
Industry
2.3
vs History
9
vs Industry
26
Median 3Y
4.6
Median 5Y
4.7
Industry
2.9
Forward
5.4
vs History
4
vs Industry
32
Median 3Y
6.6
Median 5Y
7
Industry
5.5
vs History
3
vs Industry
28
Median 3Y
12.8
Median 5Y
13.4
Industry
13
Forward
14.6
vs History
6
vs Industry
25
Median 3Y
16.5
Median 5Y
17.6
Industry
16.6
Forward
16.6
vs History
7
vs Industry
26
Median 3Y
17.6
Median 5Y
16.9
Industry
15.8
vs History
7
vs Industry
22
Median 3Y
22.2
Median 5Y
20.3
Industry
19.1
vs History
11
vs Industry
27
Median 3Y
2.7
Median 5Y
2.8
Industry
1.9

Multiples Across Competitors

JNJ Competitors Multiples
Johnson & Johnson Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Johnson & Johnson
NYSE:JNJ
487.2B USD 5.3 19.4 15.9 20.6
US
Eli Lilly and Co
NYSE:LLY
959.5B USD 16.1 52.1 35 37.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
CH
Roche Holding AG
SIX:ROG
246.8B CHF 4 26.2 11.8 13.3
UK
AstraZeneca PLC
LSE:AZN
209.6B GBP 4.8 29.7 108 158
CH
Novartis AG
SIX:NOVN
205.1B CHF 4.6 17.7 11.3 14.5
US
Merck & Co Inc
NYSE:MRK
250.9B USD 3.9 13.2 9.4 11.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.3 13.1 9.2 10.7
IE
Endo International PLC
LSE:0Y5F
202.5B USD 87.3 -69.3 321.2 805.4
US
Pfizer Inc
NYSE:PFE
146.1B USD 2.3 14.9 7.6 10.3
FR
Sanofi SA
PAR:SAN
102.9B EUR 1.5 7.5 6.8 6.8
P/E Multiple
Earnings Growth PEG
US
Johnson & Johnson
NYSE:JNJ
Average P/E: 21.5
19.4
29%
0.7
US
Eli Lilly and Co
NYSE:LLY
52.1
50%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
CH
Roche Holding AG
SIX:ROG
26.2
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.7
38%
0.8
CH
Novartis AG
SIX:NOVN
17.7
18%
1
US
Merck & Co Inc
NYSE:MRK
13.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.1
7%
1.9
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.9
31%
0.5
FR
Sanofi SA
PAR:SAN
7.5
26%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Johnson & Johnson
NYSE:JNJ
Average EV/EBITDA: 398.4
15.9
8%
2
US
Eli Lilly and Co
NYSE:LLY
35
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
CH
Roche Holding AG
SIX:ROG
11.8
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108
10%
10.8
CH
Novartis AG
SIX:NOVN
11.3
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.4
7%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
9.2
6%
1.5
IE
E
Endo International PLC
LSE:0Y5F
321.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
FR
Sanofi SA
PAR:SAN
6.8
9%
0.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Johnson & Johnson
NYSE:JNJ
Average EV/EBIT: 1 708.2
20.6
14%
1.5
US
Eli Lilly and Co
NYSE:LLY
37.5
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
CH
Roche Holding AG
SIX:ROG
13.3
6%
2.2
UK
AstraZeneca PLC
LSE:AZN
158
22%
7.2
CH
Novartis AG
SIX:NOVN
14.5
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.1
9%
1.2
DK
Novo Nordisk A/S
CSE:NOVO B
10.7
6%
1.8
IE
E
Endo International PLC
LSE:0Y5F
805.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
10%
1
FR
Sanofi SA
PAR:SAN
6.8
15%
0.5